173 related articles for article (PubMed ID: 30324908)
1. CD95/Fas ligand mRNA is toxic to cells.
Putzbach W; Haluck-Kangas A; Gao QQ; Sarshad AA; Bartom ET; Stults A; Qadir AS; Hafner M; Peter ME
Elife; 2018 Oct; 7():. PubMed ID: 30324908
[TBL] [Abstract][Full Text] [Related]
2. CD95/Fas ligand induced toxicity.
Haluck-Kangas A; Peter ME
Biochem Soc Trans; 2023 Feb; 51(1):21-29. PubMed ID: 36629505
[TBL] [Abstract][Full Text] [Related]
3. CD95/Fas ligand mRNA is toxic to cells through more than one mechanism.
Haluck-Kangas A; Fink M; Bartom ET; Peter ME
Mol Biomed; 2023 Apr; 4(1):11. PubMed ID: 37059938
[TBL] [Abstract][Full Text] [Related]
4. Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanism.
Putzbach W; Gao QQ; Patel M; van Dongen S; Haluck-Kangas A; Sarshad AA; Bartom ET; Kim KA; Scholtens DM; Hafner M; Zhao JC; Murmann AE; Peter ME
Elife; 2017 Oct; 6():. PubMed ID: 29063830
[TBL] [Abstract][Full Text] [Related]
5. Identification of DISE-inducing shRNAs by monitoring cellular responses.
Patel M; Peter ME
Cell Cycle; 2018; 17(4):506-514. PubMed ID: 29092660
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the Contribution of 6-mer Seed Toxicity to HIV-1-Induced Cytopathicity.
Vaidyanathan A; Taylor HE; Hope TJ; D'Aquila RT; Bartom ET; Hultquist JF; Peter ME
J Virol; 2023 Jul; 97(7):e0065223. PubMed ID: 37310263
[TBL] [Abstract][Full Text] [Related]
7. Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid rafts.
Lang I; Fick A; Schäfer V; Giner T; Siegmund D; Wajant H
J Biol Chem; 2012 Jul; 287(28):24026-42. PubMed ID: 22645131
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of CD95 and CD95L mRNA expression in chronic and acute HIV-1 infection by competitive RT-PCR.
Pinti M; Nasi M; Moretti L; Mussini C; Petrusca D; Esposito R; Cossarizza A
Ann N Y Acad Sci; 2000; 926():46-51. PubMed ID: 11193040
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic overexpression of CD95L in esophageal adenocarcinoma cells overcomes resistance to CD95-mediated apoptosis.
Watson GA; Naran S; Zhang X; Stang MT; Queiroz de Oliveira PE; Hughes SJ
Neoplasia; 2011 Mar; 13(3):198-205. PubMed ID: 21390183
[TBL] [Abstract][Full Text] [Related]
10. DISE: A Seed-Dependent RNAi Off-Target Effect That Kills Cancer Cells.
Putzbach W; Gao QQ; Patel M; Haluck-Kangas A; Murmann AE; Peter ME
Trends Cancer; 2018 Jan; 4(1):10-19. PubMed ID: 29413418
[TBL] [Abstract][Full Text] [Related]
11. FasR and FasL in colorectal cancer.
Szarynska M; Olejniczak A; Wierzbicki P; Kobiela J; Laski D; Sledzinski Z; Adrych K; Guzek M; Kmiec Z
Int J Oncol; 2017 Sep; 51(3):975-986. PubMed ID: 28766682
[TBL] [Abstract][Full Text] [Related]
12. The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation-induced cell death in leukemic T cells.
Bourkoula K; Englert C; Giaisi M; Köhler R; Krammer PH; Li-Weber M
Int J Cancer; 2014 Jan; 134(2):291-300. PubMed ID: 23832418
[TBL] [Abstract][Full Text] [Related]
13. Expression of biologically active mouse and human CD95/APO-1/Fas ligand in the baculovirus system.
Mariani SM; Matiba B; Sparna T; Krammer PH
J Immunol Methods; 1996 Jun; 193(1):63-70. PubMed ID: 8690931
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models.
Quijano-Rubio C; Silginer M; Weller M
J Neurooncol; 2022 Nov; 160(2):299-310. PubMed ID: 36355258
[TBL] [Abstract][Full Text] [Related]
15. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.
Eberle J; Fecker LF; Hossini AM; Wieder T; Daniel PT; Orfanos CE; Geilen CC
Oncogene; 2003 Dec; 22(57):9131-41. PubMed ID: 14668794
[TBL] [Abstract][Full Text] [Related]
16. CD95 and CD95L promote and protect cancer stem cells.
Ceppi P; Hadji A; Kohlhapp FJ; Pattanayak A; Hau A; Liu X; Liu H; Murmann AE; Peter ME
Nat Commun; 2014 Nov; 5():5238. PubMed ID: 25366259
[TBL] [Abstract][Full Text] [Related]
17. CD95 ligand is a proliferative and antiapoptotic signal in quiescent hepatic stellate cells.
Reinehr R; Sommerfeld A; Häussinger D
Gastroenterology; 2008 May; 134(5):1494-506. PubMed ID: 18471522
[TBL] [Abstract][Full Text] [Related]
18. RISC assembly: Coordination between small RNAs and Argonaute proteins.
Kobayashi H; Tomari Y
Biochim Biophys Acta; 2016 Jan; 1859(1):71-81. PubMed ID: 26303205
[TBL] [Abstract][Full Text] [Related]
19. Generation and Application of Bioluminescent CD95 Ligand Fusion Proteins.
Lang I; Kums J; Wajant H
Methods Mol Biol; 2017; 1557():63-77. PubMed ID: 28078583
[TBL] [Abstract][Full Text] [Related]
20. CD95 ligand expression in dedifferentiated breast cancer.
Müschen M; Moers C; Warskulat U; Niederacher D; Betz B; Even J; Lim A; Josien R; Beckmann MW; Häussinger D
J Pathol; 1999 Nov; 189(3):378-86. PubMed ID: 10547600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
